Validations of Top and Novel Susceptibility Variants in All-Age Chinese Patients With Acute Lymphoblastic Leukemia
Validations of Top and Novel Susceptibility Variants in All-Age Chinese Patients With Acute Lymphoblastic Leukemia
复制标题
中国全年龄段急性淋巴细胞白血病患者的主要和新的易感性变异的验证
DOI:
10.3389/fgene.2020.01004
复制
发表时间:
2020-08-25
影响因子:
3.7
通讯作者:
Lu, Xiaoxi
中科院分区:
文献类型:
--
作者:
Liao, Fei;Ye, Yuanxin;Lu, Xiaoxi
Through genome-wide association studies (GWAS), multiple inherited predispositions to acute lymphoblastic leukemia (ALL) have been identified in children. Most recently, a novel susceptibility locus atERGwas localized, exhibiting Hispanic-specific manner. In this study, we conducted a replication study to in all-age Chinese patients (N= 451), not only validating the novelERGlocus, but also systematically determining the impact of age on association status of the top GWAS signals. We found that single nucleotide polymorphisms atARID5B,IKZF1,CEBPE,PIP4K2Awere only significantly associated with ALL susceptibility in childhood patients with noBCR-ABLfusion, whileGATA3signal exhibited its significance in adults no matter carryingBCR-ABLfusion or not. Moreover, the novelERGSNP can be validated in pediatric patients without bothBCR-ABLandETV6-RUNX1fusion. Our finding suggests the modifying effects of age on genetic predisposition to ALL, and highlights the impact ofERGSNP in Chinese patients.